CLINICAL_TRIALS
trial_result
· 2012-05-15
Clinical Trial Update: Karenitecin in Pediatric Patients With Refractory or Recurrent Solid Tumors N10010) [Phase 1]
Summary
Phase 1 pediatric trial of Karenitecin in patients with refractory or recurrent solid tumors has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Baylor College of Medicine | Conditions: Solid Tumors | Phase 1 | Status: COMPLETED